Skip to content
ES
MARKETS / NASDAQ / SRTS
NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP

Sensus Healthcare, Inc. SRTS

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$27.5M
▼ 34.3% YoY
$-7.7M
▼ 216.1% YoY
$332,000
In brief

What this company does

The Company operates as one segment from its corporate headquarters located in Boca Raton, Florida. As of December 31, 2025, the Company had installed 955 units in 21 countries, primarily in the United States. In February 2024, the Company formed Sensus Healthcare Services, LLC, a wholly owned subsidiary that provides operational healthcare offerings to dermatology clinics in the form of equipment, radiation oncology and physicist oversight, and on-site device operation by radiotherapy technologists.

Written from the business description in Sensus Healthcare, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 4 March 2026. Every sentence was checked against that document before publication.

Growth
USD 27.5M
Revenue, FY2025 · full 11-year series below
Revenue $M Net income $M
FY2025 · Revenue 27.5 · Net income -7.7
20M40M-4M201520172019202120232025
Compound annual growth
−14.9%
+23.5%
+10.3%
−49.0%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +23.5% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−28 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -37.5% · Net -28.1%
20%40%-50%201520172019202120232025
ROE
FY2025 · ROE -14.9%
20%40%60%-10%-20%201520172019202120232025
Gross margin43.2%
Operating margin-37.5%
Net margin-28.1%
Return on assets-13.4%
EBITDAUSD -9.9M

Each USD of equity lost 15 cents this year.

Cash & shareholders
USD 300,000.00
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 0.3
-4M-8M201520172019202120232025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 0.3
0.8M1.6M202220232025
Dividends paid—
Net buybacksUSD 300,000.00
Share of profit-3.9%
Consecutive raises—

USD 300,000.00 in buybacks went back to shareholders in a year without profit.

Total assetsUSD 53.0M
EquityUSD 48.1M
CashUSD 22.1M
Current ratio9.72×

Equity funds 91% of total assets.

The 11-year record
11 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 20252024202320222021202020192018201720162015
Revenue $B0.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.00.0−0.00.00.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.00.0−0.00.00.0−0.0−0.0−0.0−0.0−0.00.0
Income tax $B−0.00.00.00.0·······
Net income $B−0.00.00.00.00.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−0.470.410.031.460.25−0.42−0.10−0.14−0.28−0.03−0.08
Dividend / sh $···········
Payout %···········
ROE %−14.912.71.065.517.3−27.6−6.2−10.6−27.5−3.3−4.0
Shares out B0.020.020.020.020.020.020.020.020.010.010.01

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 55 reconciliationsAUDITED

Reconciled in 11 of 19 fiscal years. 40 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2015

Share this section

Download image